| 发明名称 |
Combination Of Dopamine Agonists Plus First Phase Insulin Secretagogues For The Treatment Of Metabolic Disorders |
| 摘要 |
The present invention is directed to a method of treating a metabolic disorder or key elements of a metabolic disorder such method comprising the use of an agent(s) that increases central dopaminergic activity plus a first-phase insulin secretagouge. |
| 申请公布号 |
US2015024995(A1) |
申请公布日期 |
2015.01.22 |
| 申请号 |
US201414506353 |
申请日期 |
2014.10.03 |
| 申请人 |
VeroScience LLC |
发明人 |
Cincotta Anthony H. |
| 分类号 |
A61K38/28;A61K31/451;A61K38/26;A61K31/4985;A61K31/4745 |
主分类号 |
A61K38/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a metabolic disorder or key elements of a metabolic disorder such method comprising the step of administering to a patient an agent(s) that increases central dopaminergic activity plus a first-phase insulin secretagouge. |
| 地址 |
Tiveron RI US |
